Literature DB >> 28326574

Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.

Young-Joo Kim1, Hyungjin Rhee1, Jeong Eun Yoo1, Venancio A F Alves2, Gi Jeong Kim1, Hye Min Kim1, Paulo Herman3, Aline Chagas4, Haeryoung Kim5, Young Nyun Park1.   

Abstract

AIMS: The scirrhous variant of hepatocellular carcinoma (S-HCC) and fibrolamellar HCC (FL-HCC) are less common subtypes of HCC that are characterized by abundant fibrous stroma. Here, we aimed to investigate differences in the tumour microenvironment and the tumour epithelial cell characteristics of S-HCC and FL-HCC. METHODS AND
RESULTS: Whole tissue sections of 17 S-HCCs and 9 FL-HCCs were subjected to immunohistochemical stains for keratin 7 (K7), K19, EpCAM, CD56/NCAM, CD163, CD68, pSTAT3, FAP, CCN2 and Ki-67. FL-HCC patients were younger than S-HCC patients (P < 0.001), and chronic liver disease was seen in the background of 88.2% of S-HCC and in none of the FL-HCC. CD68 and CD163-positive tumour-infiltrating macrophages, and FAP-positive cancer-associated fibroblasts (CAFs) were more abundant in the stroma of S-HCCs compared to FL-HCCs (all P < 0.05). Tumour epithelial K19 expression was more frequent in S-HCCs compared to FL-HCCs (P = 0.023). Significant positive correlations were seen between pSTAT3 expression status in tumour epithelial cells and CAFs, the extent of stromal CAF and macrophage infiltration and K19 expression status. No significant differences were seen for K7, EpCAM, CD56/NCAM, CCN2 expression and Ki-67 labelling index between S-HCCs and FL-HCCs.
CONCLUSION: S-HCC and FL-HCC are subtypes of HCC with extensive fibrosis, and the nature of the fibrous stroma differs between them. While the stroma of FL-HCC is composed of dense lamellated collagenous bands with sparse cellular components, S-HCC demonstrates more abundant CAF and tumour-infiltrating macrophages and stemness-related marker expression, suggesting the presence of a complex tumour microenvironment that may influence the aggressive behaviour of S-HCCs.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer-associated fibroblast; fibrolamellar hepatocellular carcinoma; scirrhous hepatocellular carcinoma; tumour microenvironment

Mesh:

Year:  2017        PMID: 28326574     DOI: 10.1111/his.13219

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

2.  Response comparison of PLC and SLC with magnetic resonance elastography after TACE.

Authors:  Y Haas; M P Dosch; T J Vogl
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.

Authors:  Ximin Shi; Haiqun Xing; Xiaobo Yang; Fang Li; Shaobo Yao; Hui Zhang; Haitao Zhao; Marcus Hacker; Li Huo; Xiang Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-29       Impact factor: 9.236

4.  Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.

Authors:  Michael Praktiknjo; Viktoria Krabbe; Alessandra Pohlmann; Matthias Sampels; Christian Jansen; Carsten Meyer; Christian P Strassburg; Jonel Trebicka; Maria A Gonzalez Carmona
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

5.  Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma.

Authors:  Katerina Zakka; Renjian Jiang; Olatunji B Alese; Walid L Shaib; Christina Wu; Joel P Wedd; Marty T Sellers; Madhusmita Behera; Bassel F El-Rayes; Mehmet Akce
Journal:  J Hepatocell Carcinoma       Date:  2019-07-22

6.  Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Erik Schulz; Anthe Suzan Sterkenburg; Philipp Mayer; Jan Pfeiffenberger; Katrin Hoffmann
Journal:  J Hepatocell Carcinoma       Date:  2021-10-22

7.  Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma.

Authors:  Xiaoyuan Chen; Yiwei Lu; Xiaoli Shi; Guoyong Han; Long Zhang; Chuangye Ni; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

8.  The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt.

Authors:  Dina Sweed; Enas Sweed; Inas Moaz; Asmaa Mosbeh; Yahya Fayed; Sara Mohamed Abd Elhamed; Eman Sweed; Mahmoud Macshut; Shimaa Abdelsattar; Shimaa Kilany; Sara A Saied; Reda Badr; Mahmoud S Abdallah; Nermine Ehsan
Journal:  World J Surg Oncol       Date:  2022-09-19       Impact factor: 3.253

9.  The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes.

Authors:  Baojia Zou; Xialei Liu; Baimeng Zhang; Yihang Gong; Chaonong Cai; Peiping Li; Jiafan Chen; Shan Xing; Jianxu Chen; Siqi Peng; Bibesh Pokhrel; Lei Ding; Linjuan Zeng; Jian Li
Journal:  J Cancer       Date:  2018-09-07       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.